TY - JOUR
T1 - Keep out! SARS-CoV-2 entry inhibitors
T2 - their role and utility as COVID-19 therapeutics
AU - Chitsike, Lennox
AU - Duerksen-Hughes, Penelope
N1 - © 2021. The Author(s).
PY - 2021/7/23
Y1 - 2021/7/23
KW - Antibodies
KW - Covid-19
KW - Emerging sarbecoviruses
KW - Prophylaxis
KW - SARS-CoV-2
KW - SARS-CoV-2 variants
KW - Viral entry inhibitors
KW - COVID-19 Drug Treatment
KW - Pandemics
KW - COVID-19 Vaccines/pharmacology
KW - Humans
KW - SARS-CoV-2/drug effects
KW - Angiotensin-Converting Enzyme 2/metabolism
KW - Serine Endopeptidases/drug effects
KW - Antibodies, Viral/immunology
KW - Spike Glycoprotein, Coronavirus/metabolism
KW - COVID-19/epidemiology
KW - Cathepsins/metabolism
KW - Mutation
KW - Antibodies, Neutralizing/immunology
KW - Virus Internalization/drug effects
UR - https://www.scopus.com/pages/publications/85111561441
UR - https://www.scopus.com/pages/publications/85111561441#tab=citedBy
UR - https://www.mendeley.com/catalogue/fe289f24-cf1d-3114-a25e-16a23333ce58/
U2 - 10.1186/s12985-021-01624-x
DO - 10.1186/s12985-021-01624-x
M3 - Review article
C2 - 34301275
AN - SCOPUS:85111561441
SN - 1743-422X
VL - 18
JO - Virology Journal
JF - Virology Journal
IS - 1
M1 - 154
ER -